Impact of Erythropoiesis-Stimulating Agents on Behavioral Measures in Children Born Preterm

• Published in: The Journal of pediatrics Vol. 184; pp. 75 - 80.e1
• Main Authors: Lowe, Jean R., PhD, Rieger, Rebecca E., MS, Moss, Natalia C., MS, Yeo, Ronald A., PhD, Winter, Sarah, MD, Patel, Shrena, MD, Phillips, John, MD, Campbell, Richard, PhD, Baker, Shawna, RN, Gonzales, Sean, BS, Ohls, Robin K., MD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2017
• Subjects: Child Behavior - drug effects; Child, Preschool; cognitive development; darbepoetin; Darbepoetin alfa - pharmacology; Emotions - drug effects; erythropoietin; Erythropoietin - pharmacology; Family Characteristics; Female; Hematinics - pharmacology; Humans; Infant, Newborn; Infant, Premature; Male; neurodevelopmental outcome; Pediatrics; Socioeconomic Factors; very low birth weight; Epo; Erythropoiesis-stimulating agents; very low birth weight; BASC-2; SEC; ESA; Darbe; neurodevelopmental outcome; cognitive development; Behavioral Assessment System of Children – Second Edition; Socioeconomic Composite; Darbepoetin alfa; darbepoetin; erythropoietin

Objective To evaluate the impact of erythropoiesis-stimulating agents (ESAs) administered during initial hospitalization and family demographic factors on behavior at 3.5-4 years of age. Study design Children were enrolled who had previously participated in a randomized study of ESAs (n = 35) or pla...